AKTX

Akari Therapeutics PLC

Price

$9.20

return (12m)

-70.13%

p/e

-0.46

p/bv

0.81

DIVIDEND YIELD

0.00%

AKTX price

Akari Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment AKTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.46%

3 months

-1.02%

1 year

-70.13%

2 years

-89.35%

5 years

-99.34%

10 years

-99.86%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AKTX

Valuation

P/E

-0.46

Sector 0.84

Industry -1.42

P/BV

0.81

Sector 1.82

Industry 1.25

P/Revenue (PSR)

Sector 1.48

Industry 2.13

EV/EBITDA

Sector -43.66

Industry -35.45

EV/EBIT

Sector -47.57

Industry -38.86

P/EBITDA

-0.48

Sector -31.25

Industry -21.12

P/EBIT

-1.27

Sector -42.58

Industry -25.59

P/Total Assets

0.39

Sector 0.82

Industry 0.70

P/Net Current Assets

-1.29

Sector -23.77

Industry -59.56

P/Working Capital

-2.68

Sector -3.73

Industry -1.93

EPS

-18.32

Sector -0.70

Industry -1.22

BVPS

10.38

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

0.00%

Sector 49.32%

Industry 49.70%

EBITDA Margin

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

0.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

0.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

Sector 0.13

Industry 0.06

Profitability

ROE

-176.48%

Sector -24.30%

Industry -38.97%

ROA

-84.96%

Sector -24.50%

Industry -49.14%

ROIC

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.60

Sector 1.92

Industry 2.55

Net Debt / EBITDA

Sector -23.10

Industry -8.80

Net Debt / EBIT

Sector -17.84

Industry -36.75

Net Debt / Equity

Sector -0.68

Industry -1.16

Gross Debt / Equity

Sector -0.72

Industry -0.54

Equity/Assets

0.48

Sector 0.46

Industry 0.52

Liabilities/Assets

0.52

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

13.50%

Sector -

Industry -

Fundamentals AKTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AKTX Akari Therapeutics PLC	$9.20	-71.25%	0.00%	-0.46	0.81	-176.48%	0.00%
LLY Eli Lilly and Compay	$1,249.76	56.65%	0.53%	42.13	33.21	78.84%	33.53%
SNY Sanofi	$39.81	-18.25%	4.38%	3.78	0.70	18.43%	14.25%
GSK GlaxoSmithKline PLC	$49.36	16.30%	3.58%	15.38	4.34	28.24%	14.54%
CRMD CorMedix Inc.	$7.48	-26.52%	0.00%	3.04	1.23	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$25.97	9.21%	0.00%	14.41	1.47	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$13.05	-9.04%	0.64%	29.37	2.65	9.03%	10.14%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
NVS Novartis AG	$150.19	16.49%	2.05%	22.56	6.86	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$673.79	25.46%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
DHR Danaher Corporation	$224.14	8.20%	0.63%	40.42	3.08	7.61%	15.95%
HCA HCA Healthcare Inc.	$454.64	7.19%	0.66%	14.90	-31.76	-213.15%	8.77%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AKTX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Akari Therapeutics

Akari Therapeutics PLC

Average Investor10 user rating

4.0 (2 people)

United States

22 years

Founded: 2004

2015

Time since IPO - 11 years

20

Employees

Akari Therapeutics PLC (United States) is listed on the Nasdaq and has a market capitalization of $15.05 million, with shareholders equity totaling $18.60 million.

The company employs approximately 20 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Akari Therapeutics PLC reported $- in revenue, generating net income of $-32.82 million.

Key financial metrics include a P/E ratio of -0.46, a price-to-book (P/B) ratio of 0.81, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AKTX.

Market cap

$15.05 million

Net worth

$18.60 million

$18,595,000.00

Assets

$38.62 million

$38,624,000.00

Total Shares Outstanding

1.79 million

1,791,000

Average Daily Trading Volume

$981.17 Thousand

$981,174.00

Sector

Health

Industry

Pharmaceutical Products

AKTX

AKTX revenue and profits

Financial Results AKTX

DRAG THE FRAME TO SEE MORE DATA

AKTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76